- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Intermediate syndrome
Total 38156 results
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Anemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Low to Intermediate-1 MDSUnited States, France
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
M.D. Anderson Cancer CenterMDS Clinical Research ConsortiumCompleted
-
Genzyme, a Sanofi CompanyCompletedMyelodysplastic Syndromes | Secondary Acute Myeloid Leukemia (AML)United States
-
Associazione Qol-oneActive, not recruitingMyelodysplastic Syndromes | ThrombocytopeniaFrance, Germany, Italy, Slovenia
-
CelgeneAcceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme...CompletedMyelodysplastic SyndromesCanada, United States, Germany, Belgium, France, United Kingdom, Turkey, Spain, Italy, Netherlands, Sweden
-
Incyte CorporationTerminated
-
Amphivena Therapeutics, Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Montefiore Medical CenterAlbert Einstein College of MedicineWithdrawnMyelodysplastic SyndromesUnited States
-
Ascension South East MichiganWithdrawn
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USACompleted
-
University of ChicagoNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand, Switzerland
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
Mesoblast International SàrlNo longer availableModerate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19United States
-
M.D. Anderson Cancer CenterCompleted
-
Array Biopharma, now a wholly owned subsidiary...CompletedMyelodysplastic SyndromesUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedMyelodysplastic SyndromesUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Novartis PharmaceuticalsTerminatedAnemia | Myelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.Withdrawn
-
AstraZenecaApproved for marketingNF type1 With Inoperable Plexiform NeurofibromasUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterGlaxoSmithKlineTerminated
-
CelgeneTerminatedMyelodysplastic SyndromeUnited States
-
National Eye Institute (NEI)Terminated
-
Fakultas Kedokteran Universitas IndonesiaUnknownVogt-Koyanagi-Harada Disease | Behçet Disease | Posterior Uveitis | Intermediate Uveitis | Autoimmune Uveitis | Idiopathic Uveitis | Noninfectious Panuveitis | Anterior Uveitis IdiopathicIndonesia
-
Brigham and Women's HospitalMassachusetts General Hospital; Duke University; Weill Medical College of Cornell...CompletedAcute Respiratory Distress Syndrome (ARDS)United States
-
Guy's and St Thomas' NHS Foundation TrustUnknownCoronary Artery Disease | Chest Pain | Acute Coronary Syndrome | Ischemic Heart DiseaseUnited Kingdom
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Yonsei UniversityTerminatedAcute Coronary Syndrome | Acute Myocardial Infarction | Unstable Angina (Intermediate Coronary Syndrome)Korea, Republic of
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Associazione Qol-oneTerminatedMyelodysplastic SyndromesFrance, Italy, Greece
-
Helsinn Healthcare SACompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelodysplastic SyndromeUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedMyelodysplastic SyndromesItaly
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLeukemiaUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedAcute Coronary SyndromeFrance
-
University of Sao Paulo General HospitalUnknownChest Pain | Acute Coronary SyndromeBrazil
-
AmgenCompletedMDSGermany, Italy, Belgium, Czechia, Switzerland, France, Austria, Greece, Spain
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
Pharnext SACompletedCharcot-Marie-Tooth Disease | Hereditary Neuropathy With Liability to Pressure Palsies | Genetic DisordersFrance
-
University of AarhusCompleted
-
Wake Forest University Health SciencesAmerican Heart AssociationCompletedChest Pain | Acute Coronary SyndromeUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
Washington University School of MedicineCTI BioPharmaWithdrawnMyelodysplastic Syndromes | Myelofibrosis | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Myeloproliferative Neoplasm | Atypical Chronic Myeloid Leukemia
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States